Table 3.

Clinicopathologic features and cytogenetic karyotype results of 25 patients with IGH gene rearrangement.

Case No.	Sex	Age(years)	Rai	Flow Score	Karyotype
						1	M	77	0	4	47,XY,+12,t(14;18)(q32;q21)[15]/46,XY[5]
2	M	49	IV	4	46,XY,t(14;18)(q32;q21)[10]
3	M	69	0	4–5	46,XY,del(13)(q14),t(14;18)(q32;q21)[5] /46,XY[15]
4	M	70	I	4	46,XY,t(14;18)(q32;q21)[3]/46,XY[12]
5	M	58	IV	3	46,XY,t(14;18)(q32;q21)[10]
6	F	60	0	4	47,XX, t(14;18)(q32;q21),+18[10]
7	F	65	I	4–5	46,XX,del(13)(q12q22),t(14;18)(q32;q21)[2]/46,XX[18]
8	M	46	I	4–5	47,XY,+12,t(14;18)(q32;q21)[5]/46,XY[5]
9	M	59	III	4	47,XY,+12,t(14;18)(q32;q21)[3]/46,XY[7]
10	M	62	II	4	47,XY,+12,t(14;18)(q32;q21)[13]/46,XY[7]
11	M	63	IV	3	47,XY,+12,t(14;19)(q32;q13)[20]
12	M	54	IV	4	44,XY,t(6;8)(q13;p21),t(14;19)(q32;q13), add(17)(p13),-18,-20[2]/46,XY[18]
13	M	46	I	3	85~90,XXYY,del(6)(q21),-7,-8,-10,+12,-13,t(14;19)(q32;q13)×2,-15,-18[cp10]
14	F	40	II	3	46,XX[9]/46,XX,del(6)(q24)[1]/46,XX,t(2;14)(p13;q32),del(6)(q13),del(11)(q14)[10]
15	M	73	I	3	45,X,-Y,del(3)(p24),der(4)t(4;11)(p16;q14),del(6)(q23),del(7)(q32),t(7;14)(q21.2;q12),del(17)(p13),add(19)(q13.4)[10]
16	M	50	IV	3	46,XY,t(9;14)(p13;q32)[5]/46,XY[5]
17	M	56	IV	4	46,XY,i(8)(q10),add(18)(p11)[10]
18	M	65	III	3	46,XY,+1,del(1)(p22),t(1;21)(p34;p11),del(4)(q28),add(4)(q35),add(5)(p15), add(6)(p24),add(7)(p22),t(7;13)(p21;q21),add(12)(q24),add(17)(p13), add(17)(q25),del(18)(p11)add(19)(p13),add(21)(q22),+20,+21,+22[cp10]
19	F	72	0	3	47,XX,dup(1)(q12q44),+12[7]/46,XX[13]
20	M	50	I	4–5	46,XY[13]
21	M	55	I	4	46,XY[20]
22	M	75	II	3	46,XY[20]
23	M	56	IV	4–5	46,XY[20]
24	F	65	II	3	NA
25	M	61	IV	3	NA

F, female; M, male; NA, not available; ND, not done; FISH, fluorescence in situ hybridization; IGHV, immunoglobulin heavy variable.